|
|
||||||||||||||
|
|
|||||||||||||||
Robert-Rössle-Klinik
at the Max Delbrück Centre for Molecular Medicine, Department of
Surgery and Surgical Oncology, Charité, Campus Buch, 13125 Berlin,
Germany
Correspondence to: Dr W Kemmner, Max Delbrück Centre for Molecular Medicine, Robert-Rössle-Str 10, D-13092 Berlin, Germany wkemmner{at}mde-berlin.de
Accepted for publication 16 September 1999
BACKGROUND/AIMS
Biosynthesis
of carbohydrate structures is tissue specific and developmentally
regulated by glycosyltransferases such as fucosyltransferases, sialyltransferases, and N-acetylgluco-
saminyltransferases. During carcinogenesis, aberrant glycosylation
leads to the development of tumour subpopulations with different
adhesion properties. Therefore alterations in glycosyltransferase mRNA
expression in colorectal carcinomas were examined by semiquantitative
reverse transcription-polymerase chain reaction (RT-PCR).
METHODS
Colorectal
carcinoma specimens were classified and characterised according to the
WHO/UICC system. Expression of fucosyltransferases FT-I, FT-III, FT-IV,
FT-V, FT-VI, and FT-VII, sialyltransferases ST3Gal-I, ST3Gal-III,
ST3Gal-IV, and ST6Gal-I,
1,4-galacto- syltransferase, and
1,6-Nacetylgluco-
saminyltransferase V (GNT-V) was screened simultaneously in
extracts of 22 homogenised tumour specimens by RT-PCR and compared with
corresponding mucosa from each patient. Also 12 adenomas and 17 liver
metastases of colorectal carcinomas were examined.
RESULTS
GNT-V
expression was enhanced in colorectal adenomas (p = 0.039), carcinomas
(p<0.001), and liver metastases of colorectal carcinomas (p<0.001).
Also, expression of fucosyltransferase FT-IV was increased in
colorectal adenomas (p = 0.039) and carcinomas (p<0.001). In addition,
fucosyltransferase FT-I (p<0.001) and sialyltransferases ST6Gal-I (p = 0.004) and ST3Gal-III (p = 0.001) showed increased expression in
carcinoma specimens. On the other hand, fucosyltransferase FT-III was
less abundantly expressed in carcinomas exhibiting distant metastases
(p = 0.046) and in highly invasive tumours (p = 0.041).
CONCLUSIONS
Glycosyltransferase
mRNA expression is significantly altered in colorectal adenomas and
carcinomas isolated from surgical specimens. RT-PCR determination of
specific glycosyltransferases may be helpful for earlier detection of
carcinomas and for tumour prognosis.
This article has been cited by other articles:
![]() |
K. Miyazaki, K. Ohmori, M. Izawa, T. Koike, K. Kumamoto, K. Furukawa, T. Ando, M. Kiso, T. Yamaji, Y. Hashimoto, et al. Loss of Disialyl Lewisa, the Ligand for Lymphocyte Inhibitory Receptor Sialic Acid-Binding Immunoglobulin-Like Lectin-7 (Siglec-7) Associated with Increased Sialyl Lewisa Expression on Human Colon Cancers Cancer Res., July 1, 2004; 64(13): 4498 - 4505. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Handerson and J. M. Pawelek {beta}1,6-branched Oligosaccharides and Coarse Vesicles: A Common, Pervasive Phenotype in Melanoma and Other Human Cancers Cancer Res., September 1, 2003; 63(17): 5363 - 5369. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saito, E. Miyoshi, K. Sasai, N. Nakano, H. Eguchi, K. Honke, and N. Taniguchi A Secreted Type of beta 1,6-N-Acetylglucosaminyltransferase V (GnT-V) Induces Tumor Angiogenesis without Mediation of Glycosylation. A NOVEL FUNCTION OF GnT-V DISTINCT FROM THE ORIGINAL GLYCOSYLTRANSFERASE ACTIVITY J. Biol. Chem., May 3, 2002; 277(19): 17002 - 17008. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schneider, W. Kemmner, W. Haensch, G. Franke, S. Gretschel, U. Karsten, and P. M. Schlag Overexpression of Sialyltransferase CMP-Sialic Acid:Gal{beta}1,3GalNAc-R {{alpha}}6-Sialyltransferase Is Related to Poor Patient Survival inHuman Colorectal Carcinomas Cancer Res., June 1, 2001; 61(11): 4605 - 4611. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kumamoto, Y. Goto, K. Sekikawa, S. Takenoshita, N. Ishida, M. Kawakita, and R. Kannagi Increased Expression of UDP-Galactose Transporter Messenger RNA in Human Colon Cancer Tissues and Its Implication in Synthesis of Thomsen-Friedenreich Antigen and Sialyl Lewis A/X Determinants Cancer Res., June 1, 2001; 61(11): 4620 - 4627. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |